FASTinov presents new ultra-rapid diagnostics at the Congress of the Portuguese Society of Clinical Pathology (SPPC) in Figueira da Foz, Portugal.
FASTinov participated in the XII SPPC congress that took place in Figueira da Foz from 2-4 March (link here). The company presented the newly launched technology.
The well-attended FASTinov sponsored symposium featured three notable speakers, who presented the clinical challenges of sepsis, described the technological details of FASTinov’s two-hour susceptibility tests, revealed the results of the first use in a hospital, and discussed the organizational implications of introducing ultra-fast susceptibility testing.
FASTinov developed ultra-rapid, phenotypic antibiotic susceptibility tests for bloodstream infections that deliver antibiograms in less than 2 hours, based upon patented technologies. The company is based in Porto, Portugal.
- For press inquiries, please contact: email@example.com
Share with friends